These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308 [TBL] [Abstract][Full Text] [Related]
23. Carnitine deficiency during valproic acid treatment. Van Wouwe JP Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002 [TBL] [Abstract][Full Text] [Related]
24. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting. Helmstaedter C; Witt JA Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473 [TBL] [Abstract][Full Text] [Related]
25. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
26. Serum carnitine levels in children with iron-deficiency anemia with or without pica. Citak EC; Citak FE; Kurekci AE Pediatr Hematol Oncol; 2006; 23(5):381-5. PubMed ID: 16728358 [TBL] [Abstract][Full Text] [Related]
27. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Rauchenzauner M; Griesmacher A; Tatarczyk T; Haberlandt E; Strasak A; Zimmerhackl LB; Falkensammer G; Luef G; Högler W Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Chou IJ; Lin KL; Wang HS; Wang CJ Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941 [TBL] [Abstract][Full Text] [Related]
30. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Montouris G; Abou-Khalil B Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728 [TBL] [Abstract][Full Text] [Related]
31. Carnitine deficiency associated with anticonvulsant therapy. Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272 [TBL] [Abstract][Full Text] [Related]
32. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Belcastro V; Striano P; Gorgone G; Costa C; Ciampa C; Caccamo D; Pisani LR; Oteri G; Marciani MG; Aguglia U; Striano S; Ientile R; Calabresi P; Pisani F Epilepsia; 2010 Feb; 51(2):274-9. PubMed ID: 19780797 [TBL] [Abstract][Full Text] [Related]
33. [New antiepileptic drugs in pregnancy: outcome of 12 exposed pregnancies]. Cissoko H; Jonville-Béra AP; Autret-Leca E Therapie; 2002; 57(4):397-401. PubMed ID: 12422560 [TBL] [Abstract][Full Text] [Related]
34. Newer antiepileptic drugs and non surgical approaches in epilepsy. Singhi PD Indian J Pediatr; 2000 Jan; 67(1 Suppl):S92-8. PubMed ID: 11129899 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of renal tubular function in children taking anti-epileptic treatment. Unay B; Akin R; Sarici SU; Gok F; Kurt I; Gokcay E Nephrology (Carlton); 2006 Dec; 11(6):485-8. PubMed ID: 17199783 [TBL] [Abstract][Full Text] [Related]
37. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs. Thom H; Carter PE; Cole GF; Stevenson KL Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. Neufeld MY; Kogan E; Chistik V; Korczyn AD Clin Neuropharmacol; 1999; 22(2):80-6. PubMed ID: 10202602 [TBL] [Abstract][Full Text] [Related]
39. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068 [TBL] [Abstract][Full Text] [Related]
40. Teratogenicity of the newer antiepileptic drugs--the Australian experience. Vajda FJ; Graham J; Roten A; Lander CM; O'Brien TJ; Eadie M J Clin Neurosci; 2012 Jan; 19(1):57-9. PubMed ID: 22104350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]